3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Esophageal Squamous Cell Carcinoma
23
Carcinoma, Hepatocellular
23
Stomach Neoplasms
14
Colorectal Neoplasms
13
Liver Neoplasms
7
Esophageal Neoplasms
6
Rectal Neoplasms
5
Pancreatic Neoplasms
4
Cholangiocarcinoma
4
Locally Advanced Rectal Cancer
3
Biliary Tract Neoplasms
3
Advanced Pancreatic Cancer
3
Turcot syndrome
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Microsatellite Stable Metastatic Colorectal Cancer
2
Klatskin Tumor
2
Gallbladder Neoplasms
2
Early Low Rectal Cancer
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma of the Stomach
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Carcinoma of Esophagus
1
Sarcoma
1
Radiotherapy
1
Pathologic Complete Response
1
Pancreatic Cancer Metastatic
1
Interventions
pembrolizumab
5
Nivolumab
5
Ipilimumab
4
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
durvalumab
2
atezolizumab
2
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Celecoxib
2
tislelizumab
1
spartalizumab
1
sintilimab
1
regorafenib
1
fludarabine phosphate
1
fludarabine
1
danvatirsen
1
camrelizumab
1
Taxes
1
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Interleukin-2
1
Immunoglobulin G
1
IMM-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Turcot syndrome
×
toripalimab
×
Gastrointestinal
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled